Free Trial

Microbix Biosystems Q3 2023 Earnings Report

Microbix Biosystems logo
C$0.44 +0.01 (+1.16%)
As of 01:59 PM Eastern

Microbix Biosystems EPS Results

Actual EPS
-C$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Microbix Biosystems Revenue Results

Actual Revenue
$5.53 million
Expected Revenue
$4.80 million
Beat/Miss
Beat by +$730.00 thousand
YoY Revenue Growth
N/A

Microbix Biosystems Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Microbix Biosystems Earnings Headlines

Microbix & API Ensuring Flu Tests Can Detect H5N1 Strain
He’s without a doubt the best stock picker we’ve ever met.
There are very few people in this world who are considered “the best” in their field. There are guys like Michael Jordan who is considered the best basketball player of all time… Or Warren Buffet who is considered the best Investor of all time… But we’ve just met a man who might be the best stock picker of all time… Right now, as we speak, he is currently ranked the #1 stock picker in North America.
Microbix Biosystems: Strong Q4 Performance and Promising Growth Prospects
Microbix Biosystems Reports Record Revenue Growth
See More Microbix Biosystems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Microbix Biosystems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Microbix Biosystems and other key companies, straight to your email.

About Microbix Biosystems

Microbix Biosystems (TSE:MBX), a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

View Microbix Biosystems Profile

More Earnings Resources from MarketBeat